Reanalysis of the Mayo Lung Project data: The impact of confounding and effect modification

Journal of Medical Screening

Volumn 6, Issue 1, 1999, Pages 47-49

  Marcus, Pamela M ^a   Prorok, Philip C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Clinical trial; Lung neoplasms; Mass screening; Mayo Lung Project

Indexed keywords

ANALYTIC METHOD; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; DATA ANALYSIS; LUNG CANCER; MASS SCREENING; RISK FACTOR; THORAX RADIOGRAPHY;

EID: 0032957188     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.6.1.47     Document Type: Article

References (9)

1. Fontana RS, Sanderson DR. Screening for lung cancer: a progress report. In: Mountain CF, Carr DT, eds. Lung cancer: current status and prospects for the future. Austin: University of Texas Press, 1986:51-7.
2. Strauss GM, Gleason RE, Sugarbaker DJ. Screening for lung cancer. Another look; a different view. Chest 1997;111: 754-68.
3. Wolpaw DR. Early detection in lung cancer. Case finding and screening. Med Clin North Am 1996;80:63-82.
4. Altman DG. Comparability of randomized groups. The Statistician 1985;34:125-36.
5. Clark RA. Screening for specific cancers: breast cancer. In: Reintgen DS, Clark RA, eds. Cancer screening. St Louis: Mosby, 1996:23-40.
6. Fontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening: the Mayo Program. J Occup Med 1986;28:746-50.
7. Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo clinic study. Am Rev Respir Dis 1984;130:561-5.
8. SAS/STAT Software: Changes and enhancements through release 6.11. Cary, NC: SAS Institute, 1996.
9. Taylor WF, Fontana RS. Biometric design of the Mayo Lung Project for early detection and localization of bronchogenic carcinoma. Cancer 1972;30:1344-7.